During this phase, platelet aggregation leads to the release of various chemotactic factors, including platelet-derived growth factors: PDGF, TGF-β1, and TGF-β2, which recruit inflammatory cells such as neutrophils, macrophages, and leukocytes to the wound site, thereby providing protection against infection. The gene discussed is TGFB1; the disease is infection.